Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 randomized double-blind placebo-controlled study of OPC-131461 in healthy adult males
jRCT2071200061Phase 1Completed
- Sponsor
- Otsuka Holdings
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of OPC-131461 in heart failure (HF) (4 arms), sponsored by Otsuka Holdings. Primary endpoints: Plasma pharmacokinetics of OPC-131461, Urine output and renal pharmacodynamics and 10 more. Started Dec 2020; status: completed.
02
Drugs
OPC-131461
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on jRCT2071200061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200061.